Takeaways from the most recent news in the technology and policies shaping healthcare.
Insurers and the rules of getting paid: coverage, prior authorization, claims, denials, and the friction between health plans and the providers they reimburse.
CVS Caremark named 25-year company veteran Keith Reynolds as chief growth officer as Chief Sales Officer Jim Fowler retires.
Why it matters: CVS Caremark is one of the largest PBMs in the US, and its growth strategy shapes drug costs for millions as regulators scrutinize the industry.
A year after HR 1, Medicaid faces looming eligibility checks and work requirements, with six states serving as bellwethers for coverage and financial impact.
Why it matters: Medicaid churn drives uncompensated care and margin pressure for hospitals while reshaping insurer enrollment ahead of 2027 rule changes.
UnitedHealthcare is adding reimbursement limits on five lab test categories across its major plan lines, with most policies effective Sept. 1.
Why it matters: New payer limits mean more denials and documentation burden for labs and physicians ordering these tests.
A handful of insurers are exiting or scaling back Medicare Advantage markets as rising medical costs, federal cuts, and star-rating disputes pressure profits.
Why it matters: Insurer pullbacks mean fewer plan choices for seniors and shifting payer dynamics for hospitals and medical groups.
Providers win the vast majority of No Surprises Act arbitration cases, pushing health plans to fix out-of-network claims before they reach costly IDR.
Why it matters: Losing 88% of arbitration cases makes out-of-network claims a persistent, avoidable cost driver for health plans.
AI detection tools have matured enough to catch the more than $100 billion in annual U.S. healthcare fraud, shifting the challenge from technology to adoption.
Why it matters: Fraud, waste, and abuse inflate costs across the entire system, and proactive AI detection could finally recover dollars that reactive audits never touched.
Cigna CEO Brian Evanko says insurers back surprise-billing protections but see clear abuses of the No Surprises Act's arbitration system, joining a growing payer pushback.
Why it matters: How the arbitration fight is resolved will shape out-of-network reimbursement and the balance of power between insurers and providers.
Humana will exit Medicare Advantage plans covering about 600,000 members in 2027 as it prioritizes margin recovery, aiming to retain a portion of that volume.
Why it matters: Humana's retreat signals that major insurers are shrinking unprofitable Medicare Advantage plans, disrupting coverage for members and payer mix for providers.
Providence, Carle Health and Michigan Medicine are winding down owned insurance plans, testing whether provider-sponsored health plans can survive.
Why it matters: Owning a health plan was pitched as the future of integrated care, but the recent closures show the strategy carries real financial risk for providers.
The lapse of ACA enhanced premium tax credits is boosting some insurers' margins while pushing more uninsured patients onto hospitals.
Why it matters: The subsidy cliff is splitting the industry, rewarding payers with a leaner risk pool while saddling hospitals with rising uncompensated care.
Big payers continue expanding into health services, but they are getting more selective about which bets to keep and which to unwind.
Why it matters: How insurers diversify into care delivery reshapes competition, margins, and the boundary between coverage and care for the entire industry.
A MedCity News Bullseye panel argued that rising U.S. drug spending is not improving patient access, and that pricing transparency and PBM reform are needed to fix it.
Why it matters: Rising drug spend without better access signals a broken pricing system that transparency reforms could realign toward patients.
Second-quarter earnings show the largest U.S. insurers leaning harder on services units as tightening insurance margins push them beyond core coverage.
Why it matters: As payers become diversified healthcare conglomerates, their control over pharmacies, clinics and data reshapes competition and care across the industry.
A year after insurers pledged to simplify prior authorization for plans covering 257 million Americans, progress is real but incomplete.
Why it matters: Prior authorization delays care and burdens clinicians, so whether insurers deliver on these pledges directly affects patients and providers.
A Delaware judge dismissed UnitedHealth's defamation lawsuit against The Guardian over its reporting on Medicare Advantage nursing home payments.
Why it matters: The ruling protects investigative reporting on Medicare Advantage practices and signals insurers face long odds using defamation suits against the press.
Specialty drug costs are climbing, and payers relying on a single trend metric miss the real drivers hidden across pharmacy and medical benefits.
Why it matters: Specialty drugs are the fastest-growing piece of healthcare spend, and payers cannot manage what a single trend number conceals.
Medicare Advantage plans are making care transitions a strategic priority to strengthen Star Ratings and protect CMS bonus payments.
Why it matters: Star Ratings determine billions in Medicare bonus payments, and care transitions are one of the clearest ways plans can move the needle.
CVS Health CEO David Joyner told The Washington Post that GLP-1 drugs don't yet deliver enough downstream savings to justify their price for employers.
Why it matters: CVS controls a major PBM, so its stance influences whether millions of workers get coverage for costly weight-loss drugs.
A Missouri patient was hospitalized after Humana delayed her immune treatment, months after insurers pledged to fix prior authorization.
Why it matters: It shows that voluntary insurer pledges to fix prior authorization have not yet protected patients who depend on timely access to costly drugs.
Health plan employees are increasingly anxious that AI will replace their jobs, a fear sharpened by payer layoffs and Centene's buyout offers.
Why it matters: How payers manage AI-driven workforce fears will shape retention and morale across an industry already cutting jobs.